IN172886B - - Google Patents
Info
- Publication number
- IN172886B IN172886B IN84BO1991A IN172886B IN 172886 B IN172886 B IN 172886B IN 84BO1991 A IN84BO1991 A IN 84BO1991A IN 172886 B IN172886 B IN 172886B
- Authority
- IN
- India
- Prior art keywords
- enzymes
- target site
- enzyme
- target
- antibody
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6815—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6883—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy
- A61K47/6885—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy the conjugate or the polymer being a starburst, a dendrimer, a cascade
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/94—Involves covalent bonding to the substrate
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Genetics & Genomics (AREA)
- Birds (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Peptides Or Proteins (AREA)
- Cosmetics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909006328A GB9006328D0 (en) | 1990-03-21 | 1990-03-21 | Cell killing |
GB909021671A GB9021671D0 (en) | 1990-10-05 | 1990-10-05 | Delivery of agents |
Publications (1)
Publication Number | Publication Date |
---|---|
IN172886B true IN172886B (ja) | 1993-12-25 |
Family
ID=26296815
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN84BO1991 IN172886B (ja) | 1990-03-21 | 1991-03-21 |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0450800B1 (ja) |
JP (1) | JPH04234821A (ja) |
AT (1) | ATE139704T1 (ja) |
AU (1) | AU642979B2 (ja) |
BR (1) | BR9101118A (ja) |
CA (1) | CA2038577C (ja) |
DE (1) | DE69120452T2 (ja) |
ES (1) | ES2088464T3 (ja) |
IN (1) | IN172886B (ja) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9021671D0 (en) * | 1990-10-05 | 1990-11-21 | Unilever Plc | Delivery of agents |
AU642980B2 (en) * | 1990-03-21 | 1993-11-04 | Quest International B.V. | Ultilization of enzymes |
US5486360A (en) * | 1993-04-22 | 1996-01-23 | St. Joseph Health Centre | Method of treating tumour cells using catalase |
WO1997023241A1 (en) * | 1995-12-21 | 1997-07-03 | Quest International B.V. | Particle compositions |
US5972355A (en) * | 1997-09-30 | 1999-10-26 | E-L Management Corp. | Stable compositions containing biologically active components |
US5871714A (en) * | 1997-10-16 | 1999-02-16 | Pharmacal Biotechnologies, Inc. | Compositions for controlling bacterial colonization |
EP1787627A1 (en) | 2005-11-17 | 2007-05-23 | 3M Innovative Properties Company | Anti-microbial dental impression material |
CN103261430A (zh) | 2010-12-20 | 2013-08-21 | 纳幕尔杜邦公司 | 靶向过水解酶 |
KR20130132936A (ko) | 2010-12-20 | 2013-12-05 | 이 아이 듀폰 디 네모아 앤드 캄파니 | 구강 관리 제품에 사용하기 위한 효소에 의한 과산 생성 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1433593A (en) * | 1972-06-09 | 1976-04-28 | Royal College Of Surgeons | Conjugates |
US4657853A (en) * | 1984-09-14 | 1987-04-14 | E. I. Du Pont De Nemours And Company | Immunoassays utilizing covalent conjugates of polymerized enzyme and antibody |
DE3786000T3 (de) * | 1986-08-18 | 1997-08-21 | Dow Chemical Co | Conjugate dichter Sterne. |
US4943525A (en) * | 1987-11-02 | 1990-07-24 | Bioventures, Inc. | Simultaneous immunoassay for the determination of antigens and antibodies |
SE461570B (sv) * | 1988-06-06 | 1990-03-05 | Rama Bio Link Ab | Farmaceutiskt preparat och konjugat av en baktericid och en antikropp |
EP0361908A3 (en) * | 1988-09-28 | 1990-09-05 | Ideon Corporation | Combination enzyme immunotherapeutics |
-
1991
- 1991-03-18 AU AU72996/91A patent/AU642979B2/en not_active Ceased
- 1991-03-19 CA CA002038577A patent/CA2038577C/en not_active Expired - Fee Related
- 1991-03-20 EP EP91302397A patent/EP0450800B1/en not_active Expired - Lifetime
- 1991-03-20 JP JP3130820A patent/JPH04234821A/ja active Pending
- 1991-03-20 DE DE69120452T patent/DE69120452T2/de not_active Expired - Fee Related
- 1991-03-20 AT AT91302397T patent/ATE139704T1/de not_active IP Right Cessation
- 1991-03-20 ES ES91302397T patent/ES2088464T3/es not_active Expired - Lifetime
- 1991-03-21 BR BR919101118A patent/BR9101118A/pt not_active Application Discontinuation
- 1991-03-21 IN IN84BO1991 patent/IN172886B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2038577C (en) | 2001-06-19 |
DE69120452T2 (de) | 1996-10-31 |
EP0450800A1 (en) | 1991-10-09 |
DE69120452D1 (de) | 1996-08-01 |
CA2038577A1 (en) | 1991-09-22 |
AU642979B2 (en) | 1993-11-04 |
BR9101118A (pt) | 1991-11-05 |
EP0450800B1 (en) | 1996-06-26 |
ATE139704T1 (de) | 1996-07-15 |
AU7299691A (en) | 1991-10-03 |
JPH04234821A (ja) | 1992-08-24 |
ES2088464T3 (es) | 1996-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001294541A1 (en) | Mammalian genes; related reagents and methods | |
AU6135101A (en) | Mammalian receptor proteins; related reagents and methods | |
AU2910197A (en) | Antibodies to the ed-b domain of fibronectin, their construction and uses | |
LU90854I2 (fr) | Anticorps monoclonal chim-rique humain - murine qui se lie avec une haute affinit- - la fois - la forme soluble et - la forme transmembranaire de tnf-a mais pas - la lymphotoxine-a (tnf-beta) ou un sel ou d-riv- pharmaceutiquement acceptable de celui-ci en particulier un ester un -ther un sulfate un carbonate un glucuronide en particulier l'infliximab | |
EP1378525A3 (en) | Humanized antibodies that bind to the antigen bound by antibody NR-LU-13 and their use in pretargeting methods | |
WO2001090358A3 (en) | Mammalian receptor proteins; related reagents and methods | |
CY1109093T1 (el) | Πρωτεϊνες των υποδοχεων θηλαστικων, σχετικα αντιδραστηρια και σχετικες μεθοδοι | |
IN172886B (ja) | ||
WO2001036467A3 (en) | Mammalian receptor proteins; related reagents and methods | |
ES2088463T3 (es) | Uso de enzimas. | |
EP0257778A3 (en) | Apolipoprotein b-specific monoclonal antibodies produced by two novel hybridomas | |
WO1999046379A3 (en) | Human receptor proteins; related reagents and methods | |
GB9319877D0 (en) | Novel hybridoma & monoclonal antibodies produced thereby | |
ES2082132T3 (es) | Composicion que contiene al menos dos anticuerpos distintos o fragmentos de ellos. | |
WO1999019480A3 (en) | Human receptor proteins; related reagents and methods |